Sten Sörensen leaves SynAct Pharma’s board
Sten Sörensen has resigned from the board of SynAct Pharma to focus on his executive responsibilities.
Sörensen, who is CEO of Cereno Scientific, said his professional commitments have increased significantly and that he can no longer dedicate the time a board position at SynAct deserves. SynAct Chairman Anders Kronborg thanked him for his contributions during an important period for the company.
“It has been a privilege to serve on the Board of SynAct, and I have greatly enjoyed working with the management team and my fellow Board members,” says Sten Sörensen.
Published: November 18, 2026
